Systematic and prioritized prevention
Lundbeck’s research, development and manufacturing activities are based on chemical synthesis. Consequently, we use considerable amounts of organic solvents, energy and generate waste and emissions to the air. We are managing these environmental impacts effectively and we apply an integrated approach to Health, Safety and Environment (HSE) because it helps us prioritise and motivates collaboration across our global organisation. The efforts are prioritised in our HSE Strategy and managed through an ISO14001 and OHSAS 18001 certified HSE System.
Clean processes and technology
We have the privilege of being a research-based company, which essentially means that we design the manufacturing processes from scratch. In this process, our skilled chemists are working to prevent pollution and challenge conventional ways of thinking, for instance, by substituting chemicals to minimise the impact on the environment. We also apply the continuous improvements after having established an efficient manufacturing process. An example is the recovery of used solvents that leads to lower environmental impacts and saves costs. Over the years, we have refined our skills and technical capabilities to increase the recovery of organic solvents. In 2018, we managed to recover 76% of the most used solvents. This eliminated the need to purchase approx. 5,600 tons of solvents and consequently saved additional resources for external production, transportation and waste management.
Ambitious reduction target
Climate change is one of the most significant environmental challenges to modern civilisation. Our long-term target includes a 30% reduction of our scope 1 and 2 emissions in 2026 compared to 2016. Our scope 3 emission target includes an absolute target based on recovery of solvents and process optimizations. Furthermore, we have a behaviour related scope 3 target. Through engagement with our most CO2 emitting suppliers we will motivate them to develop climate targets. Our long-term climate target is aligned with the principles in the Paris Agreement, UN Climate Change Conference of the Parties (COP-21). The target’s level of reduction (Scope 1 and 2) corresponds to the reduction that is required by all nations to keep the global warming below two degrees in 2100.
Applying new knowledge
Medicines are vital in the treatment of disease in humans. However, the release of medicines into the environment can lead to adverse impacts. We aim to minimise this potential environmental impact by keeping our manufacturing processes closed and by safeguarding our distribution of finished goods. As part of obtaining marketing authorisation, we assess the environmental properties and impacts of the new medicinal products. The gained knowledge is applied to improve the design of manufacturing process and informing our patients about the safe disposal of unused medicine.
Health, Safety & Environment Strategy
Lundbeck has a Health Safety and Environment (HSE) strategy to ensure a prioritized, coordinated and long-term HSE effort.
Learn more about the strategy